Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was a big mover last session with its shares rising just over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month's volatile price range of $1.26 to $1.48.
This biotechnology company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Lexicon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider stocks like ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Gilead Sciences Inc. (NASDAQ: GILD) and Illumina Inc. (NASDAQ: ILMN). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This biotechnology company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Lexicon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider stocks like ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Gilead Sciences Inc. (NASDAQ: GILD) and Illumina Inc. (NASDAQ: ILMN). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
LEXICON PHARMA (NASDAQ: LXRX): Free Stock Analysis Report
ANI PHARMACEUT (NASDAQ: ANIP): Free Stock Analysis Report
ILLUMINA INC (NASDAQ: ILMN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research